Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation

J Heart Lung Transplant. 2022 Sep;41(9):1214-1217. doi: 10.1016/j.healun.2022.05.017. Epub 2022 May 27.
No abstract available

Keywords: anticoagulation; low molecular weight heparin; total artificial heart.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects
  • Bioprosthesis* / adverse effects
  • Blood Coagulation
  • Heart Valve Prosthesis Implantation*
  • Heart, Artificial*
  • Heparin
  • Heparin, Low-Molecular-Weight / adverse effects
  • Humans

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Heparin